Intriguingly and similarly to our results, targeting HGF/MET in combination with tumor irradiation (but not tumor irradiation alone) prolonged survival in the SMA-560 glioma model but did not affect radiosensitivity in vitro35. This evidence concerns the gene HGF and central nervous system cancer.